T'order is an information technology company specializing in tablet ordering and advertising platforms for food and beverage brands. As a market leader in tablet-based ordering systems, T'order has deployed over 250,000 tablets, engaging more than 25 million monthly active users. The company's innovative digital solutions go beyond standard digital menus, providing a comprehensive platform that enhances customer experiences and creates targeted advertising opportunities. T'order effectively transforms customer interaction data into actionable insights, fostering mutually beneficial relationships between establishments and their guests. With a strong presence established in South Korea, T'order is actively expanding its operations internationally, leveraging its advanced technology and data-driven approach to drive the digital transformation of the F&B industry. The company’s products include a unique glass panel design instead of conventional plastic touch panels, offering superior performance while helping clients reduce monthly operating costs.
T'order is an information technology company specializing in tablet ordering and advertising platforms for food and beverage brands. As a market leader in tablet-based ordering systems, T'order has deployed over 250,000 tablets, engaging more than 25 million monthly active users. The company's innovative digital solutions go beyond standard digital menus, providing a comprehensive platform that enhances customer experiences and creates targeted advertising opportunities. T'order effectively transforms customer interaction data into actionable insights, fostering mutually beneficial relationships between establishments and their guests. With a strong presence established in South Korea, T'order is actively expanding its operations internationally, leveraging its advanced technology and data-driven approach to drive the digital transformation of the F&B industry. The company’s products include a unique glass panel design instead of conventional plastic touch panels, offering superior performance while helping clients reduce monthly operating costs.
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. It develops RISC-V core intellectual property and cloud-based SoC design platforms to create custom systems for consumer and industrial IoT. The company offers end-to-end SoC design capabilities, including platform-based approaches that leverage configurable domain-specific architectures and pre-validated IP pools to accelerate development and reduce cost and risk. It collaborates with foundry partners, notably Samsung Foundry as a SAFETM DSP partner, to provide a one-stop solution for silicon designs. SemiFive aims to help customers realize AI-enabled and data-center oriented workloads through scalable, low-cost silicon solutions.
S-Alpha Therapeutics
Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.
Baum, Inc. is a Daejeon, South Korea-based company that specializes in electronic design automation (EDA) software and solutions aimed at optimizing the energy efficiency of semiconductor designs. Founded in 2016 by experienced professionals from the semiconductor industry, Baum's technology supports hardware and software for power and thermal management, thereby enhancing low-power consumption. The company's offerings cater to engineering teams across various sectors, including automotive, mobile, networking, and server markets, enabling them to improve the efficiency of their chip designs. As a privately held entity, Baum focuses on delivering innovative solutions to meet the evolving needs of its clients in the semiconductor industry.
t'order
Venture Round in 2022
T'order is an information technology company specializing in tablet ordering and advertising platforms for food and beverage brands. As a market leader in tablet-based ordering systems, T'order has deployed over 250,000 tablets, engaging more than 25 million monthly active users. The company's innovative digital solutions go beyond standard digital menus, providing a comprehensive platform that enhances customer experiences and creates targeted advertising opportunities. T'order effectively transforms customer interaction data into actionable insights, fostering mutually beneficial relationships between establishments and their guests. With a strong presence established in South Korea, T'order is actively expanding its operations internationally, leveraging its advanced technology and data-driven approach to drive the digital transformation of the F&B industry. The company’s products include a unique glass panel design instead of conventional plastic touch panels, offering superior performance while helping clients reduce monthly operating costs.
K Auction
Convertible Note in 2022
K Auction is a leading art auction house based in Korea, specializing in modern and contemporary Korean art. The company conducts various types of auctions, including major auctions, special events, charity auctions, and private collection sales. K Auction features a diverse array of artworks, showcasing pieces by prominent Korean and international artists, as well as traditional Korean arts and crafts. By providing a platform for both established and emerging talent, K Auction plays a crucial role in promoting the cultural heritage and artistic innovation of Korea.
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.
IVIM Technology
Series C in 2022
IVIM Technology, founded in 2017 and based in Daejeon, South Korea, specializes in developing and manufacturing advanced medical devices, particularly the IntraVital Microscopy platform. The company provides services such as live cell intravital imaging, repetitive intravital imaging, drug efficacy monitoring, delivery monitoring, and whole tissue 3D imaging. IVIM Technology's innovations focus on exploring cellular interactions within living organisms to understand complex human diseases better. Their technology is instrumental in analyzing the in vivo efficacy of new biopharmaceuticals, including immunological, cell, gene, and antibody therapeutic agents, at the cellular level.
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. It develops RISC-V core intellectual property and cloud-based SoC design platforms to create custom systems for consumer and industrial IoT. The company offers end-to-end SoC design capabilities, including platform-based approaches that leverage configurable domain-specific architectures and pre-validated IP pools to accelerate development and reduce cost and risk. It collaborates with foundry partners, notably Samsung Foundry as a SAFETM DSP partner, to provide a one-stop solution for silicon designs. SemiFive aims to help customers realize AI-enabled and data-center oriented workloads through scalable, low-cost silicon solutions.
Organoid Sciences
Series B in 2022
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.
Plasmapp
Venture Round in 2021
Plasmapp Co. Ltd. is a South Korean company that specializes in plasma engineering technology, focusing on the development of innovative solutions for sterilization and disinfection. Founded in 2015 and based in Daejeon, the company has created a range of products, including PMPS, a multi-purpose atmospheric plasma system designed for producing plasma-treated water and sterilizing medical devices. Additionally, Plasmapp has introduced STERPACK, a novel plasma sterilizer for medical tools, and PNCM, an in-situ NOx concentration monitoring system. The company leverages advanced plasma technologies, originally developed at KAIST, to provide state-of-the-art systems for various applications, including the unique plasma curing technology for processed meat. Plasmapp aims to be a key partner in delivering effective engineering solutions tailored to meet diverse industry needs.
Sky Labs is a technology company focused on developing innovative wearable devices for health monitoring, particularly a cuffless ring-type blood pressure monitor and a device known as the Cardio Tracker (CART). The CART is designed for continuous monitoring of atrial fibrillation, a common and often undiagnosed heart condition affecting many individuals over 40. This device can be worn comfortably on any finger and is both waterproof and dustproof, allowing users to wear it throughout their daily activities without interruption. It operates without user intervention, automatically detecting and recording atrial fibrillation, which users can track via a smartphone application. The device aims not only to assist individuals in managing their heart health but also to provide valuable data to healthcare professionals for accurate diagnosis. Sky Labs is currently conducting clinical trials in collaboration with Seoul National University Hospital to validate the performance of its technology, with an initial focus on the atrial fibrillation patient market in Finland, and an extended target market of millions worldwide. The company is also partnering with Bayer to explore further healthcare innovations.
Founded in Seoul, South Korea in 2014, Barogo operates a last-mile delivery platform that connects businesses and customers. It specializes in two-wheeled logistics, primarily focusing on food delivery services by partnering with various food outlets.
Musicow, Inc. is a company based in Seoul, South Korea, that operates an online platform facilitating the investment in music copyrights. Founded in 2017, Musicow allows musical artists to share their copyright with fans, enabling fans to invest in K-Pop songs through a public auction or an online marketplace. The platform offers users the ability to buy and sell fractional ownership of music rights, thereby creating opportunities for fans and investors to earn royalties based on the streaming and usage of the songs. Additionally, Musicow features a secondary marketplace for music copyright trading and project financing, enhancing participation in the music industry and allowing for potential returns on investments.
Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.
Amazing Brewing Company
Series B in 2021
Amazing Brewing Company is a craft beer producer and operator of a brewery and taprooms based in Seoul, South Korea. Founded in 2016, the company focuses on fresh handmade beer produced in small batches, with about 200 liters per brewing, and offers a range of craft beers including oak barrel-aged styles, lagers, ales, and a hard seltzer lineup.
Elice Inc. is a digital education company based in Daejeon, South Korea, specializing in online courses focused on coding and web application development. The company offers a range of programming courses, including languages such as C++, Python, and Java, supported by an artificial intelligence-based platform. Elice employs a three-step approach to education, encompassing training, evaluation, and recruitment, which facilitates employee digital transformation and fosters opportunities for growth and social innovation. The platform emphasizes practice-based learning, allowing students to engage in live coding sessions and receive constructive feedback, thereby equipping them with the skills to tackle real-world challenges effectively.
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.
bitsensing
Seed Round in 2020
bitsensing develops radar-based products and solutions for smart cities, automotive sensing, and autonomous driving, offering Traffic Radar to monitor real-time traffic metrics such as vehicle numbers and speed; Virtual Fence for real-time intrusion detection without a physical fence; and 4D Imaging Radar for autonomous driving. Founded in 2018 and based in Seoul, the company applies high-performance automotive-grade radar across applications including autonomous driving, connected living, smart cities, and health tech, enabling AI-powered radar sensing to create reliable, convenient environments and smart living.
Fount Inc. is an asset management Robo-Advisor company that was founded in 2015 and is headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its investing algorithm, which leverages Big Data technology and advanced computer algorithms. Fount's Robo-Advisor engine, Bluewhale, determines the optimal combination of assets by integrating financial engineering technology with asset allocation theories. The company's approach emphasizes passive investing, aiming to align investment strategies with clients' goals and risk tolerances over various time horizons. By utilizing AI technology, Fount enables clients to effectively monitor financial markets and adjust their asset allocations in response to market changes.
Musicow, Inc. is a company based in Seoul, South Korea, that operates an online platform facilitating the investment in music copyrights. Founded in 2017, Musicow allows musical artists to share their copyright with fans, enabling fans to invest in K-Pop songs through a public auction or an online marketplace. The platform offers users the ability to buy and sell fractional ownership of music rights, thereby creating opportunities for fans and investors to earn royalties based on the streaming and usage of the songs. Additionally, Musicow features a secondary marketplace for music copyright trading and project financing, enhancing participation in the music industry and allowing for potential returns on investments.
Organoid Sciences
Series A in 2020
Organoid Sciences is a biotechnology company founded in 2018 and located in Seongnam-si, South Korea. The company specializes in developing organoid-based therapies using its proprietary Keo cannabinoid technology to address various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, aiming to advance treatment options through innovative approaches.
StyleShare
Series D in 2020
StyleShare Inc. is a South Korean company founded in 2011 that specializes in designing and developing a mobile and web application focused on fashion, beauty, and lifestyle. The platform serves as a real-time space for users to share and receive updates related to these interests, allowing individuals to showcase their daily outfits and recent purchases. With millions of users across 120 countries, StyleShare has established itself as a leading mobile platform in the fashion and beauty sector, earning recognition from prominent publications such as VOGUE, Instyle, and Elle Japan. Through its innovative application, StyleShare facilitates a vibrant community where users can connect over their shared passion for fashion.
Standard Energy
Venture Round in 2019
Standard Energy is a South Korean tech startup developing vanadium ion batteries to potentially replace lithium-ion systems for energy storage.
Blocko Inc. is a South Korean company specializing in the research and development of blockchain solutions aimed at facilitating the adoption of this technology across various sectors. Founded in 2014 and based in Seongnam, Blocko offers CoinStack, a Backend-as-a-Service platform that allows users to integrate blockchain functionalities through application programming interfaces. The company provides a comprehensive suite of tools, including software development kits optimized for various environments, application monitoring tools, and technical support services. By enabling multinational organizations to design, deploy, and manage digital services on a secure distributed network, Blocko supports the implementation of advanced blockchain solutions, including AERGO, an open-source enterprise blockchain platform that emphasizes hybrid design and cloud deployment capabilities. Its services cater to a diverse clientele ranging from freelancers and startups to large enterprises, enhancing security and transparency in digital transactions.
D&D Pharmatech
Series B in 2019
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.
Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.
DAILYHOTEL
Series C in 2018
DAILYHOTEL is a lifestyle technology enabler that provides affordable access to quality experiences in accommodation, dining and travel offerings through its mobile platform. They focus on transaction through mobile app only, selling more than 100,000 room every month on average in just South Korea alone. In 2017 March, they have reached over 7million downloads for their app.
EOFlow Co., Ltd. is a South Korean company specializing in drug delivery solutions, particularly in the development of wearable insulin pumps. Its flagship product, EOPatch, is recognized as the world's smallest full-featured disposable insulin pump, designed to be smarter, better-connected, and longer-lasting than competing devices, all while being more cost-effective. The company plans to enhance EOPatch with a software upgrade that will enable closed-loop insulin control, effectively functioning as an automated insulin delivery system or "artificial pancreas." Additionally, EOFlow is working on an all-in-one wearable disposable artificial pancreas solution, which has received Breakthrough Device designation from the FDA, highlighting its potential impact on diabetes management.
Awair
Venture Round in 2018
Awair is a technology company that develops indoor air quality monitoring devices and a software platform that provides actionable insights to improve indoor environments. Its sensors measure temperature, humidity, CO2, volatile organic compounds, and particulate matter, delivering real‑time data to homeowners, schools, and workplaces. The platform aggregates the data, offers recommendations, and helps users reduce exposure to pollutants, thereby supporting health and cognitive performance. Awair is headquartered in San Francisco and has an additional office in Seoul.
D&D Pharmatech
Series A in 2018
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.
Orum Therapeutics
Series A in 2017
Orum Therapeutics is a biotechnology company developing therapeutic antibodies using its proprietary cell-penetrating antibody platform. This platform targets specific intracellular proteins for treating genetic diseases and cancer, adapting to different cell types without chemical modifications.
Bagelcode
Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.
Market Kurly
Series A in 2016
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.
Awair is a technology company that develops indoor air quality monitoring devices and a software platform that provides actionable insights to improve indoor environments. Its sensors measure temperature, humidity, CO2, volatile organic compounds, and particulate matter, delivering real‑time data to homeowners, schools, and workplaces. The platform aggregates the data, offers recommendations, and helps users reduce exposure to pollutants, thereby supporting health and cognitive performance. Awair is headquartered in San Francisco and has an additional office in Seoul.
Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.
EOFlow Co., Ltd. is a South Korean company specializing in drug delivery solutions, particularly in the development of wearable insulin pumps. Its flagship product, EOPatch, is recognized as the world's smallest full-featured disposable insulin pump, designed to be smarter, better-connected, and longer-lasting than competing devices, all while being more cost-effective. The company plans to enhance EOPatch with a software upgrade that will enable closed-loop insulin control, effectively functioning as an automated insulin delivery system or "artificial pancreas." Additionally, EOFlow is working on an all-in-one wearable disposable artificial pancreas solution, which has received Breakthrough Device designation from the FDA, highlighting its potential impact on diabetes management.
AptaBio Therapeutics
Series B in 2016
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, focused on discovering and developing innovative treatments, particularly selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers a range of transfection reagents, including Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX, designed to facilitate the introduction of DNA or RNA into eukaryotic cells. AptaBio's product pipeline includes several candidates, such as PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 intended for the treatment of non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics aims to address significant medical needs through its innovative drug development efforts.
Iamcompany
Series B in 2015
Iamcompany is a South Korea-based student startup affiliated with the KAIST Midam committee, focusing on enhancing educational engagement through internet-based technologies. The company's primary objective is to unlock students' potential by bridging communication between educational institutions and caregivers. It has developed a mobile application, 'iamschool', which delivers news and updates from various educational institutions directly to students' caregivers, allowing them to follow and stay informed about their chosen institutions. Additionally, Iamcompany offers 'iamclass', a web service that directly communicates institutional information to caregivers while also advertising educational services to their target audience. By facilitating better information flow, Iamcompany aims to create a more supportive learning environment for students in South Korea.
NHN Edu Corp. is an online educational services provider based in Seongnam, South Korea. The company specializes in designing and developing web and mobile platforms that enhance the educational experience. Its key offerings include IMS School, IMT, Union, and Pink Diary, which support teachers in managing classes and facilitating communication with parents. These platforms assist educators in monitoring student behavior and creating an effective learning environment. NHN Edu is committed to improving the quality of education through innovative technology solutions.
FraSen Inc. is a South Korean start-up specializing in sleep monitoring solutions through innovative technology. Established in 2010 and based in Seoul, the company integrates neuroscience and the Internet of Things to enhance sleep quality. FraSen's flagship product, the Neurofeedback Sleep Mask, employs ECG technology to accurately track sleep stages and utilizes sound and light stimuli to help synchronize brain waves, promoting deeper sleep. In addition to its hardware, the company offers personalized sleep care services designed to improve overall energy levels, enhance performance, and facilitate relaxation. By combining scientific principles with advanced technology, FraSen aims to provide users with effective tools for achieving better sleep and a refreshed state.
KoKomo Games
Series A in 2015
KoKomo Games is a South Korean company founded in 2014, specializing in the design and development of massively multiplayer online role-playing games (MMORPGs). Based in Seoul, the company is composed of a team with extensive experience in the gaming industry, having previously developed and launched successful titles such as Lineage2 and Blade&Soul. Unlike the current trend towards trading card and midcore RPG games, KoKomo Games aims to focus on the hardcore RPG genre, which they view as an untapped market. The company is committed to creating a flagship mobile MMORPG that appeals to gamers in Asia, leveraging the shared characteristics and interests of these audiences with those in Korea. KoKomo Games seeks to enhance the overall gaming experience by providing interactive, real-time multiplayer games that are rich in narrative and strategic elements.
Zigbang
Venture Round in 2015
Founded in Seoul, South Korea in 2010, Zigbang operates a property listing platform and application that connects real estate agents with renters. It offers an apartment hunting service, enabling users to search for rental properties based on criteria such as number of rooms, occupants, and price.
The Beatpacking Company
Series B in 2015
The Beatpacking Company is a prominent provider of ad-supported music streaming services in South Korea, operating a mobile application known as BEAT. The company specializes in developing a social mobile music streaming platform that allows users to access a diverse range of music tailored to their genre preferences. By focusing on mobile devices and smartphones, The Beatpacking Company offers a user-friendly experience that caters to the evolving needs of music listeners in the region.
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Wider Planet
Series C in 2014
Founded in Seoul, South Korea in 2010, Wider Planet operates advertising platforms globally. It analyzes digital users' preferences and interests using big data to deliver targeted marketing and advertisement contents. The company offers a demand-side platform for categorized user information, a data management platform for holistic behavioral data analysis, real-time bidding platform, and an SSP advertising tool. Additionally, it provides display and mobile advertising services.
StyleShare
Series B in 2014
StyleShare Inc. is a South Korean company founded in 2011 that specializes in designing and developing a mobile and web application focused on fashion, beauty, and lifestyle. The platform serves as a real-time space for users to share and receive updates related to these interests, allowing individuals to showcase their daily outfits and recent purchases. With millions of users across 120 countries, StyleShare has established itself as a leading mobile platform in the fashion and beauty sector, earning recognition from prominent publications such as VOGUE, Instyle, and Elle Japan. Through its innovative application, StyleShare facilitates a vibrant community where users can connect over their shared passion for fashion.